A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin.

By T. Marrie, C. Lau, Susan L. Wheeler, Cindy J. Wong, M. Vandervoort, B. Feagan. Journal of the American Medical Association (JAMA), 2000

769 citations recorded by the source corpus.

Subfields: Applied Microbiology and Biotechnology, Critical Care and Intensive Care Medicine, Epidemiology

View Paper: https://www.semanticscholar.org/paper/23ec940c652a3bb12fddeb3cbf01009949a01010

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Applied Microbiology and Biotechnology

In Critical Care and Intensive Care Medicine

In Epidemiology

Citations in the corpus

Predicting dire outcomes of patients with community acquired pneumonia (2005, background): “In related research, a controlled trial involving 1743 patients with CAP showed that the availability to clinicians of the output of a mortality-prediction model ‘‘reduced the use of institutional resources without causing adverse effects on the well-being of patients’’ [33].”
Prognosis and prognostic research: application and impact of prognostic models in clinical practice (2009, background): “A disadvantage of this design is the sensitivity to temporal changes in therapeutic approaches. Although impact studies are scarce, are a few good examples exist.”
Summary of the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Guidelines for Developing an Institutional Program to Enhance Antimicrobial Stewardship (2007, background): “7 fewer mean days of intravenous therapy in the intervention group, without an increase in complications, readmissions, or mortality [75].”
Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. (2000, background): “Such prediction rules have also facilitated the development of critical pathways for the management of CAP in the institutional setting [129, 130].”
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults (2000, neutral): “A second multicenter controlled trial subsequently assessed the effectiveness and safety of using the Pneumonia PORT prediction rule for the initial site-of-treatment decision [37].”
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. (2007, background): “7 fewer mean days of intravenous therapy in the intervention group, without an increase in complications, readmissions, or mortality [75].”